SBIR/STTR Research Award
STTR Phase I: Localized Gene Delivery from Implantable Arterial Devices
Award amount
$150,000Program and phase
STTR · Phase IAward year
2007Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- BIOSURFACES INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KML8NX2RNDD4
- Solicitation number
- NSF 06-598
- Topic code
- BT
Research abstract
This Small Business Technology Transfer (STTR) Phase I research project aims to develop a fibrous material for the embedment and gradual release of appropriate genetic material, including small interfering RNA (siRNA), and viral vectors carrying genes for anti-inflammatory molecules, from coronary stents and prosthetic grafts. With over one million stents, and 70,000 prosthetic grafts placed each year, development of a reliable material that can release biological entities such as viral vectors and siRNA can be of large benefit for the millions of individuals suffering from heart disease and other occlusive ailments.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Implantable Electrospun Cell Chamber Device with Immune-Evasive Properties for Beta Cell Replacement Therapy
- Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds
- A Bioactive Nanofibrous Sewing Cuff for Treatment of Cardiac Valvular Disease
- A Nanofibrous Bioactive Hemodialysis Access Graft
- A Bioactive Prosthetic Vascular Graft
Research funding history
14 SBIR/STTR records share this UEI (2003–2023). Reported award amounts total $6,654,426. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation